EP Patent

EP2720699A2 — Administration of benzodiazepine

Assigned to Hale BioPharma Ventures LLC · Expires 2014-04-23 · 12y expired

What this patent protects

The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.

USPTO Abstract

The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP2720699A2
Jurisdiction
EP
Classification
—
Expires
2014-04-23
Drug substance claim
No
Drug product claim
No
Assignee
Hale BioPharma Ventures LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.